ad
This Article
Right arrow Images Only
Right arrow Full Version
Services
Right arrow E-mail this link to a friend
Right arrow Related text in Red Book
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Articles in Pediatrics
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices

The first 300 words of the full text of this section appear below.

Section 3. Summaries of Infectious Diseases

Measles

Clinical Manifestations
Etiology
Epidemiology
Diagnostic Tests
Treatment
Isolation of the Hospitalized Patient
Control Measures

Top
 Next
See Images

CLINICAL MANIFESTATIONS

Measles is an acute viral disease characterized by fever, cough, coryza, conjunctivitis, an erythematous maculopapular rash, and a pathognomonic enanthema (Koplik spots). Complications including otitis media, bronchopneumonia, laryngotracheobronchitis (croup), and diarrhea occur commonly in young children. Acute encephalitis, which often results in permanent brain damage, occurs in approximately 1 of every 1000 cases. Death, predominantly resulting from respiratory and neurologic complications, occurs in 1 to 3 of every 1000 cases reported in the United States. Case fatality rates are increased in children younger than 5 years of age and immunocompromised children, including children with leukemia, human immunodeficiency virus (HIV) infection, and severe malnutrition. Sometimes the characteristic rash does not develop in immunocompromised patients.

Subacute sclerosing panencephalitis (SSPE) is a rare degenerative central nervous system disease characterized by behavioral and intellectual deterioration and seizures that occurs 7 to 10 years after wild-type measles virus infection. Widespread measles immunization has led to the virtual disappearance of SSPE in the United States.


Top
 Previous
Next
See Images

ETIOLOGY

Measles virus is an RNA virus with 1 serotype, classified as a member of the genus Morbillivirus in the Paramyxoviridae family.


Top
 Previous
Next
See Images

EPIDEMIOLOGY

The only natural hosts of measles virus are humans. Measles is transmitted by direct contact with infectious droplets or, less commonly, by airborne spread. Measles is one of the most highly communicable of all infectious diseases. In temperate areas, the peak incidence of infection usually occurs during late winter and spring. In the prevaccine era, most cases of measles in the United States occurred in preschool and young school-aged children, and few people remained susceptible by 20 years of age. The childhood and adolescent immunization program in the United States has resulted in a greater . . . [Go to Full Text]


Related text in Red Book:

Summary of Major Changes in the 2009 Red Book

Red Book 2009: XXIX. [Extract] [Full Version]  

Active Immunization of People Who Recently Received Immune Globulin

Red Book 2009: 37. [Extract] [Full Version]  

Vaccine Safety and Contraindications

Red Book 2009: 40-41. [Extract] [Full Version]  

Scheduling Immunizations

Red Book 2009: 21-31. [Extract] [Full Version]  

Minimum Ages and Minimum Intervals Between Vaccine Doses

Red Book 2009: 32. [Extract] [Full Version]  

Simultaneous Administration of Multiple Vaccines

Red Book 2009: 33-34. [Extract] [Full Version]  

Immune Globulin (Intramuscular)

Red Book 2009: 56-57. [Extract] [Full Version]  

Health Care Personnel

Red Book 2009: 94-97. [Extract] [Full Version]  

Refugees and Immigrants

Red Book 2009: 97-98. [Extract] [Full Version]  

International Travel

Red Book 2009: 98-104. [Extract] [Full Version]  

Immunocompromised Children

Red Book 2009: 72-86. [Extract] [Full Version]  

Children With a Personal or Family History of Seizures

Red Book 2009: 86. [Extract] [Full Version]  

Active Immunization After Exposure to Disease

Red Book 2009: 87-88. [Extract] [Full Version]  

Children in Residential Institutions

Red Book 2009: 90-92. [Extract] [Full Version]  

Other Infectious Diseases

Red Book 2009: 182-183. [Extract] [Full Version]  

Recommendations for Inclusion or Exclusion

Red Book 2009: 127-131. [Extract] [Full Version]  

Infectious Diseases—Epidemiology and Control

Red Book 2009: 131-138. [Extract] [Full Version]  

Rubella

Red Book 2009: 579-584. [Extract] [Full Version]  

Tuberculosis

Red Book 2009: 680-701. [Extract] [Full Version]  

Varicella-Zoster Infections

Red Book 2009: 714-727. [Extract] [Full Version]  

Human Immunodeficiency Virus Infection

Red Book 2009: 380-400. [Extract] [Full Version]  

Kawasaki Disease

Red Book 2009: 413-418. [Extract] [Full Version]  

Mumps

Red Book 2009: 468-472. [Extract] [Full Version]  

Appendix VI. Guide to Contraindications and Precautions to Immunizations

Red Book 2009: 847-853. [Extract] [Full Version]  



This topic has been referenced by these articles:

  • Groom, A. V., Washington, M. L., Smith, P. J., Bryan, R. T. (2008). Underimmunization of American Indian and Alaska Native Children. Pediatrics 121: 938-944 [Abstract] [Full Version]  
  • Haidopoulou, K., Fylaktou, A., Goutaki, M., Papadimitriou, A., Kalamitsou, S., Varlamis, G. (2008). SEROLOGICAL STUDY ON IMMUNITY TO MEASLES AND MUMPS IN NORTHERN GREEK CHILDREN. Pediatrics 121: S128-S128 [Abstract]  
  • Ward, K. N., Bryant, N. J., Andrews, N. J., Bowley, J. S., Ohrling, A., Verity, C. M., Ross, E. M., Miller, E. (2007). Risk of Serious Neurologic Disease After Immunization of Young Children in Britain and Ireland. Pediatrics 120: 314-321 [Abstract] [Full Version]  
  • Abrams, S. A., Hilmers, D. C. (2008). Postnatal Vitamin A Supplementation in Developing Countries: An Intervention Whose Time Has Come?. Pediatrics 122: 180-181 [Full Version]  
  • Offit, P. A. (2008). New Book About Vaccine Safety. Pediatrics 122: 871-872 [Full Version]  
  • Kim, J. S., Sun Jo, D., Go, U., Park, B. H., Cho, H., Oh, D.-K. (2008). NATIONAL VACCINE INJURY COMPENSATION PROGRAM IN KOREA: A 12-YEAR EXPERIENCE. Pediatrics 121: S165-S165 [Abstract]  
  • D'Angio, C. T., Boohene, P. A., Mowrer, A., Audet, S., Menegus, M. A., Schmid, D. S., Beeler, J. A. (2007). Measles-Mumps-Rubella and Varicella Vaccine Responses in Extremely Preterm Infants. Pediatrics 119: e574-e579 [Abstract] [Full Version]  
  • Spergel, J. M. (2006). Long-term Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% in Infants Does Not Interfere With the Development of Protective Antibodies After Vaccination. Pediatrics 118: S15-S16 [Abstract]  
  • Kuwaik, G., Roberts, W., Brian, J., Bryson, S., Smith, I. M., Szatmari, P., Zwaigenbaum, L. (2008). Immunization Uptake in Siblings of Children With Autism. Pediatrics 122: 684-685 [Full Version]  
  • Kosmidis, S., Pourtsidis, A., Bouhoutsou, D., Baka, M., Varvoutsi, M., Doganis, D., Kallergi, C., Douladiris, N., Synodinou, M., Saxoni-Papageorgiou, F., Kosmidis, H. (2008). IMMUNE STATUS AND IMMUNE RECOVERY IN CHILDREN WITH LYMPHOMA AT THE END OF THERAPY (CHEMOTHERAPY AND/OR RADIOTHERAPY) AND IN FOLLOW-UP EVALUATIONS. Pediatrics 121: S119-S120 [Abstract]  
  • Katz, S. L. (2006). Has the Measles-Mumps-Rubella Vaccine Been Fully Exonerated?. Pediatrics 118: 1744-1745 [Full Version]  
  • Hinman, A. R., Randall, L. H. (2008). Fighting for the Reputation of Vaccines. Pediatrics 122: 224-225 [Full Version]  
  • LeBaron, C. W., Bi, D., Sullivan, B. J., Beck, C., Gargiullo, P. (2006). Evaluation of Potentially Common Adverse Events Associated With the First and Second Doses of Measles-Mumps-Rubella Vaccine. Pediatrics 118: 1422-1430 [Abstract] [Full Version]  
  • Msall, M. E., Hogan, D. P. (2007). Counting Children With Disability in Low-Income Countries: Enhancing Prevention, Promoting Child Development, and Investing in Economic Well-being. Pediatrics 120: 182-185 [Full Version]  
  • Bernstein, H. H., Eves, K., Campbell, K., Black, S. B., Twiggs, J. D., Reisinger, K. S., Conti, R. M., Flodmark, C.-E., Rombo, L., Klopfer, S., Schodel, F., Hartzel, J., Kuter, B. J., and the Refrigerator-Stable Formulation Study Grou, (2007). Comparison of the Safety and Immunogenicity of a Refrigerator-Stable Versus a Frozen Formulation of ProQuad (Measles, Mumps, Rubella, and Varicella Virus Vaccine Live). Pediatrics 119: e1299-e1305 [Abstract] [Full Version]  
  • Gilger, M. A., Redel, C. A. (2009). Autism and the Gut. Pediatrics 124: 796-798 [Full Version]  
  • Rosenlund, H., Bergstrom, A., Alm, J. S., Swartz, J., Scheynius, A., van Hage, M., Johansen, K., Brunekreef, B., von Mutius, E., Ege, M. J., Riedler, J., Braun-Fahrlander, C., Waser, M., Pershagen, G., and the PARSIFAL Study Group, (2009). Allergic Disease and Atopic Sensitization in Children in Relation to Measles Vaccination and Measles Infection. Pediatrics 123: 771-778 [Abstract] [Full Version]  
  • American Academy of Pediatrics, (2007). AAP Publications Retired or Reaffirmed, October 2006. Pediatrics 119: 405-405 [Full Version]  
  • Retail-Based Clinic Policy Work Group, (2006). AAP Principles Concerning Retail-Based Clinics. Pediatrics 118: 2561-2562 [Full Version]